Search details
1.
A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.
Blood
; 124(25): 3768-71, 2014 Dec 11.
Article
in English
| MEDLINE | ID: mdl-25349176
2.
Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population.
Am J Clin Pathol
; 161(6): 586-597, 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38345307
3.
Differential expression of aurora-A kinase in T-cell lymphomas.
Mod Pathol
; 26(5): 640-7, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23411487
4.
A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis.
Case Reports Hepatol
; 2020: 6901514, 2020.
Article
in English
| MEDLINE | ID: mdl-32884850
5.
The role of aurora A and polo-like kinases in high-risk lymphomas.
Blood Adv
; 3(11): 1778-1787, 2019 06 11.
Article
in English
| MEDLINE | ID: mdl-31186254
6.
GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Appl Immunohistochem Mol Morphol
; 27(3): 180-184, 2019 03.
Article
in English
| MEDLINE | ID: mdl-28877074
7.
Aurora-A kinase nuclear expression in chronic lymphocytic leukemia.
Mod Pathol
; 21(12): 1428-35, 2008 Dec.
Article
in English
| MEDLINE | ID: mdl-18931650
8.
Bone marrow involvement by marginal zone B-cell lymphomas of different types.
Am J Clin Pathol
; 129(5): 714-22, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18426730
9.
Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.
Am J Clin Pathol
; 150(5): 393-405, 2018 Oct 01.
Article
in English
| MEDLINE | ID: mdl-30052721
10.
The need for rapid cytogenetics in the era of unique therapies for acute myeloid leukemia.
Blood Adv
; 6(24): 6210-6212, 2022 12 27.
Article
in English
| MEDLINE | ID: mdl-35973157
11.
Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas.
Oncotarget
; 8(70): 114474-114480, 2017 Dec 29.
Article
in English
| MEDLINE | ID: mdl-29383095
12.
Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.
Am J Clin Pathol
; 145(4): 514-23, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27124945
13.
Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature.
Case Rep Pathol
; 2015: 380451, 2015.
Article
in English
| MEDLINE | ID: mdl-26819793
14.
Comparative Analysis Reveals Potential Utility of Digital Microscopy in the Evaluation of Peripheral Blood Smears With Some Barriers to Implementation.
Am J Clin Pathol
; 144(1): 68-77, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-26071463
15.
Resistance of 3'-phosphoglycolate DNA ends to digestion by mammalian DNase III.
Radiat Res
; 157(3): 306-11, 2002 Mar.
Article
in English
| MEDLINE | ID: mdl-11839093
16.
Base substitutions, targeted single-base deletions, and chromosomal translocations induced by bleomycin in plateau-phase mammary epithelial cells.
Radiat Res
; 158(3): 327-38, 2002 Sep.
Article
in English
| MEDLINE | ID: mdl-12175310
17.
DNA end sequestration by DNA-dependent protein kinase and end joining of sterically constrained substrates in whole-cell extracts.
Environ Mol Mutagen
; 42(4): 279-87, 2003.
Article
in English
| MEDLINE | ID: mdl-14673873
18.
Plasma cell myeloma mimicking classical Hodgkin lymphoma in the bone marrow.
Int J Hematol
; 107(2): 127-128, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29027630
19.
Cystic tumor of the atrioventricular node: an unexpected finding in an explanted heart.
Cardiovasc Pathol
; 19(3): e75-8, 2010.
Article
in English
| MEDLINE | ID: mdl-19144541
20.
Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
Cancer
; 115(5): 1041-8, 2009 Mar 01.
Article
in English
| MEDLINE | ID: mdl-19170236